Skip to main content

Advertisement

SpringerLink
Log in

Is surgery always necessary in esophageal cancer?

  • Congress Report: Invited Lecture
  • Published:
Esophagus Aims and scope Submit manuscript

Abstract

Two randomized trials showed that survival was similar after definitive chemoradiation (CRT) or after CRT and surgery in locally advanced esophageal squamous cell cancer, despite more frequent local recurrences. In one trial randomization was done at inclusion, whereas in the other trial a workup was performed after initial CRT; only clinical responders were randomized between surgery and additional CRT. Therefore, clinical non-responders could be operated on without delay. Indeed, randomized patients and nonrandomized operated patients had a similar survival, even if no response was seen on the specimen. However, evidence of benefit is poor in cases of delayed recurrence. Only small nonrandomized studies have considered this issue. R0 resection rates ranged from 50 to 87%, 5-year survival rates from 0 to 33%, and operative mortality from 12.5 to 25%; only R0 resection was associated with long survival. Therefore, the benefit of delayed salvage resection should be assessed in a prospective strategic randomized trial, after a CRT intensive enough to eradicate a sensitive tumor without increasing the risk of eventual surgery. The FFCD (Fédération Francophone de Cancérologie Digestive) is working on such a trial in locally advanced operable esophageal carcinoma: CRT and systematic surgery compared with CRT followed by surgery in case of proven persistent tumor or resectable local recurrence. CRT will be improved with induction chemotherapy, new drugs, and up-to-date protracted radiotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Mariette C, Triboulet JP. Is preoperative chemoradiation effective in treatment of esophageal carcinoma? Lancet Oncol. 2005;6:635–7.

    Article  CAS  PubMed  Google Scholar 

  2. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J, Australasian Gastro-intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226–34.

    Article  CAS  PubMed  Google Scholar 

  3. Thirion PG, Michiels S, Le Maître A, Tierney J, on behalf of the Meta-analysis of Chemotherapy in Esophagus Cancer Collaborative Group. Individual patient data-based meta-analysis assessing pre-operative chemotherapy in resectable oesophageal carcinoma. J Clin Oncol 2007;25:4512 (meeting abstracts).

  4. Thirion P, Maillard E, Pignon J, Meta-analysis of Chemo in Oesophagus Cancer Collaborative Group, Individual Patient Data-based Meta-Analysis Assessing the Effect of Preoperative Chemo-Radiotherapy in Resectable Oesophageal Carcinoma. 50th American Society for Therapeutic Radiology and Oncology Meeting. Int J Radiat Oncol Biol Phys 2008;72(suppl):S71.

    Google Scholar 

  5. Jin HL, Zhu H, Ling TS, Zhang HJ, Shi RH. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. World J Gastroenterol. 2009;15:5983–91.

    Article  PubMed  Google Scholar 

  6. Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera-Knorrenschild J, Engenhart-Cabillic R, Bitzer M, Königsrainer A, Budach W, Wilke HJ, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol. 2009;27:851–6.

    Article  CAS  PubMed  Google Scholar 

  7. Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005;23:2310–7.

    Article  PubMed  Google Scholar 

  8. Bedenne L, Michel P, Bouché O, Milan C, Mariette C, Conroy T, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25:1160–8.

    Article  CAS  PubMed  Google Scholar 

  9. Thésaurus National de Cancérologie Digestive. http://www.tncd.org.

  10. Stahl M, Budach W, Meyer HJ, Cervantes A. Esophageal cancer: clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(suppl 5):v46–49.

    Google Scholar 

  11. Jouve JL, Michel P, Mariette C, Bonnetain F, Bouche O, Conroy T, et al. Outcome of the nonrandomized patients in the FFCD 9102 trial: chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus. J Clin Oncol 2008;26:226s (meeting abstract 4555).

    Google Scholar 

  12. Bates B, Detterbeck F, Bernard S, Qaqish B, Tepper J. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol. 1996;14:156–63.

    CAS  PubMed  Google Scholar 

  13. Piessen G, Briez N, Triboulet JP, Mariette C. Patients with locally advanced esophageal carcinoma non responders to radiochemotherapy: who will benefit from surgery? Ann Surg Oncol. 2007;14:2036–44.

    Article  PubMed  Google Scholar 

  14. Adelstein D, Rice T, Becker M, et al. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer (Phila). 1997;80:1011–20.

    Article  CAS  Google Scholar 

  15. Schneider P, Metzger R, Schaefer H, et al. Response evaluation by endoscopy, rebiopsy and endoscopic ultrasound does not accurately predict histopathological regression after neoadjuvant chemoradiation for esophageal cancer. Ann Surg. 2008;248:902–8.

    Article  PubMed  Google Scholar 

  16. Sarkaria I, Rizk N, Bains M, Tang L, Ilson D, Minsky B, et al. Post-treatment endoscopic biopsy is a poor-predictor of pathologic response in patients undergoing chemoradiation therapy for esophageal cancer. Ann Surg. 2009;249:764–7.

    Article  PubMed  Google Scholar 

  17. Brown W, Thomas J, Gotley D, Burmeister B, Lim K, Martin I, et al. Use of oesophagogastroscopy to assess the response of esophageal carcinoma to neoadjuvant therapy. Br J Surg. 2004;91:199–204.

    Article  CAS  PubMed  Google Scholar 

  18. Kwee RM. Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F-FDG-PET: a systematic review. Radiology. 2010;254:707–17.

    Article  PubMed  Google Scholar 

  19. Meunier B, Raoul JL, Le Prise E, Lakehal M, Launois B. Salvage esophagectomy after unsuccessful curative radiochemotherapy for squamous cell cancer of the esophagus. Dig Surg. 1998;15:224–6.

    Article  CAS  PubMed  Google Scholar 

  20. D’Journo XB, Michelet P, Dahan L, Doddli C, Seitz JF, Guidicelli R, et al. Indications and outcome of salvage surgery for esophageal cancer. Eur J Cardiothorac Surg. 2008;33:1117–23.

    Article  PubMed  Google Scholar 

  21. Nakamura T, Hayashi K, Ota M, Eguchi R, Ide H, Takasaki K, et al. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg. 2004;188:261–6.

    Article  PubMed  Google Scholar 

  22. Tomimaru Y, Yano M, Takachi K, Miyashiro I, Ishihara R, Nishiyama K, et al. Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy. J Surg Oncol. 2006;93:422–8.

    Article  PubMed  Google Scholar 

  23. Swisher S, Wynn P, Putnam J, Mosheim M, Correa A, Komaki R, et al. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg. 2002;123:175–83.

    Article  PubMed  Google Scholar 

  24. Tachimori Y, Kanamori N, Uemura N, Hokamura N, Igaki H, Kato H. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2009;137:49–54.

    Article  PubMed  Google Scholar 

  25. Oki E, Morita M, Kakeji Y, Ikebe M, Sadanaga N, Egasira A, et al. Salvage esophagectomy after definitive chemoradiotherapy for esophageal cancer. Dis Esophagus. 2007;20:301–4.

    Article  CAS  PubMed  Google Scholar 

  26. Minsky B, Pajak T, Ginsberg R, Pisansky T, Martenson J, Komaki R, et al. INT 0123 (RTOG 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20:1167–74.

    Article  CAS  PubMed  Google Scholar 

  27. Ruhstaller T, Pless M, Dietrich D, Kranzbuehler H, von Moss R, Moosmann P, et al. Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II trial (SAKK 75/06). J Clin Oncol 2011 [Epub ahead of print].

  28. Crehange G, Maingon P, Peignaux K, N’Guyen TD, Mirabel X, Marchal C, et al. Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: FFCD 9102. J Clin Oncol 2007;25:4895–4901.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hepatogastroenterology, University Hospital, CHU DIJON, 1, Bd de Lattre de Tassigny, 21034, Dijon Cedex, France

    Laurent Bedenne, Julie Vincent & Jean-Louis Jouve

  2. Fédération Francophone de Cancérologie Digestive, Faculté de Médecine, Université de Bourgogne, Dijon, France

    Laurent Bedenne, Julie Vincent & Jean-Louis Jouve

Authors
  1. Laurent Bedenne
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julie Vincent
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean-Louis Jouve
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laurent Bedenne.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bedenne, L., Vincent, J. & Jouve, JL. Is surgery always necessary in esophageal cancer?. Esophagus 8, 3–7 (2011). https://doi.org/10.1007/s10388-011-0258-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10388-011-0258-8

Keywords

Search

Navigation